{"disease":{"id":"prevention-of-hpv-types-16-and-18-related-cervical-cancer-cervical-intraepithelial-neoplasia-cin-1-2-3-and-cervical-adenocarcinoma-in-situ","name":"prevention of hpv types 16 and 18 related cervical cancer cervical intraepithelial neoplasia cin 1 2 3 and cervical adenocarcinoma in situ"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03493542","title":"A Study to Evaluate the Immunogenicity, Safety and Tolerability of Quadrivalent Human Papillomavirus Vaccine (V501) in Chinese Girls Aged 9-19 Years and Young Women Aged 20-26 Years (V501-213)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":766,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}